Insights
IDEA Collider | Pharma and Profits, with John LaMattina
In this incredible episode, Mike Rea is joined by Dr. John L. LaMattina. John is the former Senior Vice President of Pfizer Inc and President of Pfizer Global Research & Development. Additionally, he is a senior partner at PureTech Health and an author. He talks about the misconception about Pfizer’s profiteering from the pandemic and the drug pricing in America.
John also discusses how Gilead’s Sovaldi drug for hepatitis C became overpriced in the US and the effects of insurance companies on the drug market. Moreover, he talks about the misinformation about insulin and its pricing, NIH’s role in drug discovery research, and the profitability of the pharma industry.
Tune in!
Subscribe to our newsletter for more insights.
Further reading
-
Announcement
IDEA Collider | Tim Kight - Effective Leadership, Strong Organizational Culture & Behavior
IDEA Collider | Tim Kight - Effective Leadership, Strong Organizational Culture & Behavior
-
Industry
Our Obsession with “Efficacy”
Efficacy, as our CEO Mike Rea likes to remind us at IDEA Pharma, is a “banned” word in our firm


